Smeal Undergraduate Distinguished Achievement Award
Recognizes an undergraduate alumnus/alumna whose career achievements have enhanced the prestige of the college.
2016 Award Recipient: Julie McHugh '86 Finance
Julie McHugh ’86 is a 30-year veteran of the biopharmaceutical industry. Most recently, she was the chief operating officer at Endo Health Solutions where she was responsible for the pharmaceutical and generic drug businesses. Previously, McHugh held executive positions including CEO of Nora Therapeutics, company group chairman at Johnson & Johnson, and president of Centocor. During her career, she led the development and commercialization of break-through products for the treatment of cardiovascular, respiratory, gastrointestinal, autoimmune, and infectious diseases. She has led organizations ranging from small start-ups to large, complex multinational companies.
McHugh’s leadership roles have included multi-billion dollar businesses with several thousand employees. Her background includes experience in general management, strategic planning, R&D, mergers and acquisitions, and organizational design. As an operational leader, she has implemented numerous initiatives to improve effectiveness and efficiency. McHugh currently serves on the Board of Directors for Xellia Pharmaceuticals, Ironwood Pharmaceuticals, Trevena Pharmaceuticals, Epirus biopharmaceuticals, and Aerie Pharmaceuticals. In addition, she has participated on several trade association and non-profit boards, including serving as the vice chair for the Smeal Board of Visitors.
McHugh resides in Ambler, Pennsylvania with her husband Michael and their daughter Emily.